glp-1 supply news today 🚨 FDA Moves to Shut Down Mass-Market Compounded GLP-1s The FDA is taking action to restrict widely marketed, non–FDA-approved compounded products, citing concerns over safety, quality, and misleading claims. As demand GLP-1 Receptor Agonist Market Growth
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
























